editor@imedpub.com

The Selective Prostacyclin (Ip) Receptor Agonist Selexipag: A Promising Drug in Pediatric Pulmonary Artery Hypertension

Martin Koestenberger, Hannes Sallmon and Georg Hansmann

Published Date: 2017-11-10
DOI10.21767/2471-8505.100101
Visit for more related articles at
open access journals, open access scientific research publisher, open access publisher
Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Open Access Journals

Share This Article